Answer
It is licensed for adults with severe chronic rhinosinusitis with nasal polyps as add-on treatment with an intranasal corticosteroid when systemic corticosteroids and/or surgery have not provided adequate control.
Sources for this answer
- Tezspire 210 mg solution for injection in pre-filled syringe — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.